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AGENCY USE ONLY
Purpose: The purpose of this project was to investigate the utility of inducible siRNA vectors for analyzing signal transduction ,pathways in breast cancer cell lines. Scope: This was a one year project designed to test the feasibility of a novel approach, which, if it showed promise, would lead to more extensive research. Progress: Studies were initiated to test two strategies for construction of inducible siRNA vectors. These strategies made use of vectors described in publications that appeared subsequent to submission of the grant application. Four sites within the HER2 cDNA sequence -positions 672, 2190, 2796, and 4287-were identified as favorable targets for siRNA inhibition based on known properties of such sites. Vectors were constructed targeting each of these sites with the two different inducible siRNA vectors. SK-BR3 cells were obtained from ATCC and transfections were initiated to generate stable derivative lines expressing the TET repressor. After accomplishing these initial objectives, further progress was delayed because of serious illness in the P.I's family requiring a prolonged absence, together with the almost simultaneous resignation of the individual primarily assigned to the project. (2, 3) . This technology provides a powerful new tool for studying the numerous genetic and epigenetic events implicated in the pathogenesis of breast cancer. In particular, this method provides a method to approach a type of question not addressed by other methods, namely: For any given cell line, which pathways, and which specific components of those pathways, are necessary for the malignant behavior of the cell? Current vectors for stable expression of an siRNA in mammalian cell lines depend on specific RNA polymerase III (pol III) dependent promoters, which have properties compatible with synthesizing an siRNA (2-4). This proposal aimed to evaluate modifications of such vectors which would render siRNA expression inducible. The study focused on methods for introducing the tetracycline responsive element (TRE) into the pol III dependent histone Hl or U6 promoters as a means of generating an inducible siRNA expression vector. The purpose of this project was to investigate the utility of inducible siRNA vectors for analyzing signal transduction pathways in breast cancer cell lines. This was a one year project of limited scope designed to test the feasibility of a novel approach, which, if it showed promise, would lead to more extensive investigation.
BODY
Studies were initiated to test two strategies for construction of inducible siRNA vectors. Rather than constructing vectors de novo as originally proposed, we chose to begin with vectors reported to have the desired characteristics described in publications that appeared subsequent to submission of the grant application (6, 7). Four sites within the HER2 cDNA sequencepositions 672, 2190, 2796, and 4287 -were identified as favorable targets for siRNA inhibition based on known properties of such sites. Vectors were constructed targeting each of these sites with the two different inducible siRNA vectors. SK-BR3 cells were obtained from ATCC and transfections were initiated to generate stable derivative lines expressing the TET repressor.
After accomplishing these initial objectives, further progress was delayed because of serious illness in the P.I.'s family requiring a prolonged absence, together with the almost simultaneous resignation of the research biologist primarily assigned to the project. The current plan is to continue to evaluate the plasmids already constructed following the plan outlined in Tasks 3 
CONCLUSIONS
The use of inducible siRNA vectors has the potential to provide new insights into to the roles of the various signaling pathways and their individual components in the pathogenesis of breast cancer. The utility of the plasmids constructed in the initial phase of this project remains to be determined by transfection experiments.
